Capoccia L, Mestres G, Riambau V
Vascular Surgery Division Paride Stefanini Department of Surgery, Policlinico Umberto I, La Sapienza University, Rome, Italy -
J Cardiovasc Surg (Torino). 2014 Jun;55(3):381-9. Epub 2014 Feb 11.
In recent years, in parallel with the increase of endovascular aortic repair (EVAR) procedures performances, a rise of late open surgical removal of EVAR implants has been observed, due to non-endovascularly correctable graft complications. Among them endograft infection is a rare but devastating occurrence, accounting for an incidence ranging from 0.2% to 0.7% in major series, and almost 1% of all causes of endograft explantations. However, a real estimation of the incidence of the problem respect to the number of EVAR implantations is difficult to obtain. Time to infection is usually defined as the period between EVAR and presentation of symptoms that leads to the infection diagnosis. It can be extremely variable, depending on bacterial virulence and host conditions. The diagnosis of an endograft infection is usually based on a combination of clinical symptoms, imaging studies and microbial cultures whenever possible. If computed tomography (CT) scan is employed in almost 100% of infection diagnosis, a combination of fluorodeoxyglucose-positron emission tomography (FDG-PET) and CT scan is nowadays used with increasing frequency in order to rise the likelihood of detecting a graft infection, since even cultures of blood or samples collected from the infected field can sometimes be negative. Complete graft excision seems the best approach whenever a surgical reconstruction could be attempted. In situ reconstruction can be performed by the interposition of an autologous vein, a cryopreserved allograft or a rifampin-soaked Dacron graft. The so-called conventional treatment contemplates the re-establishment of vascularization through extranatomical routes, thus preserving the new graft material from possible contamination by the surgical field just cleaned. When severe comorbid conditions did not allow graft excision, a conservative treatment should be taken into account. It is mainly based on broad-spectrum or culture-specific antibiotic therapy combined, whenever possible, with percutaneous drainage of the infectious cavity or aneurismal sac followed by irrigation with saline and antibiotic solutions. New techniques of percutaneous drainage under CT scan guidance can allow expedite collection of fluid material for microbial culture or fluid drainage, catheter positioning to collect infectious material from the cavity and perform irrigation of the infected field or injection of iodine contrast when the suspicion of aortoenteric fistula exists.
近年来,随着血管腔内主动脉修复术(EVAR)手术量的增加,因非血管腔内可纠正的移植物并发症,晚期开放手术取出EVAR植入物的情况有所增多。其中,移植物感染虽罕见但极具破坏性,在主要系列研究中的发生率为0.2%至0.7%,占所有移植物取出原因的近1%。然而,很难真正估算出该问题的发生率与EVAR植入数量的关系。感染时间通常定义为EVAR与导致感染诊断的症状出现之间的时间段。其差异极大,取决于细菌毒力和宿主状况。移植物感染的诊断通常基于临床症状、影像学检查以及尽可能进行的微生物培养相结合。几乎100%的感染诊断都采用计算机断层扫描(CT),如今氟脱氧葡萄糖-正电子发射断层扫描(FDG-PET)与CT扫描联合使用的频率越来越高,以提高检测移植物感染的可能性,因为即使血液培养或从感染部位采集的样本有时也可能为阴性。只要有可能尝试进行手术重建,完整切除移植物似乎是最佳方法。原位重建可通过植入自体静脉、冷冻保存的同种异体移植物或浸有利福平的涤纶移植物来完成。所谓的传统治疗方法是通过解剖外途径重建血管化,从而使新的移植物材料免受刚刚清理过的手术区域可能的污染。当严重的合并症不允许切除移植物时,应考虑采取保守治疗。主要基于广谱或针对培养结果的抗生素治疗,并尽可能结合经皮引流感染腔或动脉瘤囊,随后用盐水和抗生素溶液冲洗。CT扫描引导下的经皮引流新技术可加快采集用于微生物培养的液体材料或进行液体引流,定位导管以从腔内采集感染物质,并在怀疑存在主动脉肠瘘时对感染区域进行冲洗或注射碘造影剂。